What is the efficacy of acarbose in reducing the incidence of type 2 diabetes mellitus (DM)?

Updated: Jul 13, 2021
  • Author: Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD  more...
  • Print

Acarbose (100 mg three times a day) was shown in the Study to Prevent Non-Insulin Dependent Diabetes Mellitus (STOP-NIDDM) to reduce diabetes rates by approximately 25% in patients at high risk for the development of type 2 diabetes. [379] This 6-year, international, multicenter, double-blind, placebo-controlled, randomized investigation included 1,368 subjects with IGT.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!